Table 1. Comparison of four major urological and andrological association's guidelines on leukocytospermia.
AUA and ASRM | CUA | EAU | |
---|---|---|---|
Definition | >1 million leukocytes per mL semen | >1 million leukocytes per mL semen | >1 million leukocytes per mL semen |
Diagnostic method | Wet mount microscopy confirmed with immunohistochemistry | N/A | Wet mount microscopy confirmed with peroxidase positive staining |
Clinical significance | May indicate underlying genital tract infection | No clinical significance | Indicate sign of genital tract inflammation only; no direct link to infection |
Diagnostic recommendation | Recommends quantification of leukocytes only in patients with unexplained male infertility or for evaluation of ART therapy options | No recommendation for evaluation of genital tract inflammation in absence of symptoms | Not included in standard semen analysis |
Treatment recommendation | N/A | Therapy not indicated, but warrants consideration in setting of infertility | Antibiotics may improve sperm quality, but no evidence that it increases the probability of conception |
Level of evidence | N/A | Treatment: 3c | Significance: 3 |
Treatment: 2a | |||
Most recent review | 2015 | 2011 | 2016 |
This table reviews the four major urologic and andrologic associations and their diagnostic method, clinical significance, diagnostic and treatment recommendations regarding leukocytospermia. Also reported is the level of evidence and the most recent update to their guidelines. The international bodies that give recommendations and that are included in this table include the American Urologic Association (AUA), the American Society for Reproductive Medicine (ASRM), the Canadian Urological Association (CAU) and the European Association of Urology (EAU). N/A indicates this component was not discussed in the respective guideline article.